12 citations
,
February 2021 in “Translational Psychiatry” Researchers found two new genetic variants linked to Alzheimer's disease.
January 2024 in “Wiadomości Lekarskie” Alzheimer's Disease (AD) affects 55 million people globally and is characterized by brain changes such as amyloid beta and tau aggregation, neuroinflammation, and neuronal death. Despite FDA-approved antibody treatments targeting amyloid-beta, no effective treatment exists, particularly for women and ApoE4 carriers. AD is increasingly seen as a multifactorial disease with neuroinflammation and gut microbiome dysbiosis playing significant roles. Recent studies suggest that pro-inflammatory gut bacteria in prodromal AD are linked to reduced cerebral blood flow and cognitive dysfunction, while beneficial bacteria are associated with better brain health. These findings highlight the potential for novel diagnostic and therapeutic approaches targeting the gut microbiome and inflammation in AD.
10 citations
,
June 2001 in “Annals of neurology” Alzheimer's patients have higher levels of certain chemicals in their hair.
July 2012 in “Alzheimer s & Dementia” Effective sleep apnea treatment may reverse cognitive decline in Alzheimer's.
3 citations
,
November 2023 in “Frontiers in Neurology” The U.S., China, and the U.K. lead Alzheimer's and white matter research.